Abstract:As normal tissues contain normal tissue stem cells (NSCs), tumors are thought to contain tumor stem cells (TSCs) which perform self-renewal and generate their progenies. TSC can be a therapeutic target; however, cancer therapies targeting TSCs are limited, because most of the TSC markers are shared by NSCs. Therefore, it is important to identify TSC-specific markers. Previously, we reported that doublecortin-like kinase 1 (Dclk1)-positive epithelial cells do not produce any progenies in the normal small intestine but supply progeny tumor cells in the tumors of Apc mice. Selective ablation of Dclk1-positive TSCs collapses the intestinal tumors of Apc mice. Therefore, Dclk1 appears to be a specific marker of TSCs in the mouse intestinal tumors. In the present study, we performed microarray analysis in order to investigate the characteristics of Dclk1-positive TSCs in the tumors of Apc mice. Dclk1-positive tumor cells had higher expression levels of cyclooxygenase 1 (Cox1), leukotriene C4 synthase (Ltc4s), and arachidonate 5-lipoxygenase activating protein (Alox5ap) than Dclk1-negative cells in the tumors of Apc mice, suggesting that Dclk1positive cells in the tumors of Apc mice had higher expression levels of the genes which were related to prostaglandin and leukotriene metabolism. As well, microarray analysis revealed that gustducin alpha and gamma subunits, transient receptor potential cation channel, subfamily M, member 5 (TRPM5), and phospholipase C beta 2 were more highly expressed in Dclk1-positive tumor cells. Thus, Dclk1-positive tumor cells seemed to possess the characteristic of Tuft cells. Furthermore, Dclk1-positive tumor cells had higher expression level of Ras-related C3 botulinum toxin substrate 2 (Rac2) than Dclk1-negative tumor cells in Apc mouse intestine. In order to elucidate the role of Rac2 in Dclk1-positive TSCs, we generated tumor spheroids from Apc mouse tumors, and administrated EHT1864, Rac inhibitor to the spheroids. Following 5-day treatment with EHT1864, the growth of the tumor spheroids was significantly suppressed. Importantly, on day1, EHT1864 treatment significantly reduced the proportion of Dclk1-positive cells in the tumor spheroids. These results suggested that Rac2 played some roles for the maintenance of the intestinal tumor spheroids. In conclusion, this study may provide new insights into the maintenance mechanisms of Dclk1-positive TSC in the intestinal tumors, and give us hints to develop novel therapeutic strategies targeting TSCs against colorectal cancers.

A Rac1/PAK1 cascade controls β-catenin activation in colon cancer cells

Rac1 Activation Controls Nuclear Localization of β-catenin during Canonical Wnt Signaling

Su2005 DCLK1 Promotes Pancreatic Cancer Cell Clonogenicity and Invasiveness

Su2003 Nrip2, a Novel Regulator of the Non-Canonical Wnt Pathway, Promotes the Self-Renewal of Colorectal Cancer Initiating Cells

P-21 Activated Kinase 1 Knockdown Inhibits Β-Catenin Signalling and Blocks Colorectal Cancer Growth.

PAK1-dependent MAPK Pathway Activation is Required for Colorectal Cancer Cell Proliferation

P21-activated Kinase 1 Promotes Colorectal Cancer Survival by Up-Regulation of Hypoxia-Inducible Factor-1Α

Depletion of P21-Activated Kinase 1 Up-Regulates the Immune System of APC∆14/+ Mice and Inhibits Intestinal Tumorigenesis

PAK5 Facilitates the Proliferation, Invasion and Migration in Colorectal Cancer Cells

Hyper activation of β-catenin signalling induced by IKKε inhibition thwarts colorectal cancer cell proliferation.

P21-Activated Kinase 5 is Overexpressed During Colorectal Cancer Progression and Regulates Colorectal Carcinoma Cell Adhesion and Migration

P21-Activated Kinase 5 Inhibits Camptothecin-Induced Apoptosis in Colorectal Carcinoma Cells

Intracellular complement C5a/C5aR1 stabilizes β-catenin to promote colorectal tumorigenesis

Rac1b enhances cell survival through activation of the JNK2/c-JUN/Cyclin-D1 and AKT2/MCL1 pathways

Oncogenic Function of DACT1 in Colon Cancer Through the Regulation of Β-Catenin.

PAK is essential for RAS-induced upregulation of cyclin D1 during the G(1) to S transition

Colorectal cancer cells secreting DKK4 transform fibroblasts to promote tumour metastasis

APC controls Wnt-induced β-catenin destruction complex recruitment in human colonocytes

Phosphorylation of PPDPF via IL6‐JAK2 activates the Wnt/β‐catenin pathway in colorectal cancer

Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC

Elevated Protein Expression of Cyclin D1 and Fra‐1 but Decreased Expression of C‐myc in Human Colorectal Adenocarcinomas Overexpressing Β‐catenin